PROCEPT BIOROBOTICS CORPORATION - COMMON STOCK

PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million

08 1 2024 16:00:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City

13 11 2023 15:03:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

01 11 2023 15:02:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023

16 10 2023 15:05:00 提供 Nasdaq GlobeNewswire

The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation

12 10 2023 07:00:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose

20 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer

12 9 2023 07:00:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan

22 8 2023 07:00:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston

17 8 2023 15:05:00 提供 Nasdaq GlobeNewswire

NorthShore University HealthSystem offers expanded access to treat most common prostate ailment

16 8 2023 07:00:01 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock

01 8 2023 21:10:39 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

01 8 2023 15:06:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

27 7 2023 06:00:01 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023

11 7 2023 15:03:00 提供 Nasdaq GlobeNewswire

Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates

28 4 2023 07:00:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance

27 4 2023 06:00:01 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics to Report First Quarter 2023 Financial Results on April 27, 2023 and Present at the Bank of America 2023 Health Care Conference in Las Vegas

05 4 2023 15:03:00 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates

03 4 2023 07:00:01 提供 Nasdaq GlobeNewswire

PROCEPT BioRobotics Corp. Announces Investor Event at 2023 AUA Annual Meeting in Chicago

30 3 2023 15:05:01 提供 Nasdaq GlobeNewswire

Aquablation Therapy is the first surgical robotics system to receive a MedTech Innovation Briefing (MIB) from the National Institute for Health Care Excellence

07 3 2023 06:00:01 提供 Nasdaq GlobeNewswire